IL6 and pneumocystosis: Adverse events reported included herpes zoster infection, Pneumocystis jirovecii pneumonia, nocardia infection, severe pancytopenia, neutropenia, and perforations of the ileum and jejunum [30].The effectiveness of other IL-6 inhibitors, such as siltuximab and sarilumab, remains limited in the current literature.